Premenstrual Dysphoric Disorder Terminated Phase 2 Trials for Ulipristal (DB08867)

Also known as: Premenstrual dysphoric disorder

IndicationStatusPhase
DBCOND0005024 (Premenstrual Dysphoric Disorder)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089414Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral ContraceptivesTreatment